Intimation about closure of trading window for Quarter ended 30th September 2026

Ru SANDU PHARMACEUTICALS LIMITED SA[\/DU CIN:L24233GA1985PLC001587 Regd. Office: Plot Nos. 25, 26, 29 & 30, Pilerne Industrial Estate, Marra, Saligao, Bardez, Goa 403511. m Tel: +91 832 2407474 / 6715000, E-mail: sandupharma@sandu.in, Website: www.sandu.in Dated:22.09.2026 Ref: Corp.Sec/2026-27/BSE/486 Department of Corporate Services, Bombay Stock Exchange Limited, Phirojshah Jeejobhoy tower, Dalal Street, Mumbai-400001. Scrip Code:524703 Sub: Intimation about the Closure of Trading Window. Respected Sir Pursuant to the “Code of Conduct for Prevention of Insider Trading” of the Company, SEBI (Prohibition of Insider Trading)Regulations, 2015 and clarification given by BSE vide its letter ref no LIST/COMP/01/2019-20 dated April 2,2019 regarding trading restrictions period, trading window for dealing in Securities of the Company shall remain closed from Thursday, 015t October 2026 till 48 hours after the declaration of the financial results of the Company for the quarter ended 30" September 2026 for Directors, KMPs, Promoters And Promoters Group and Designated Persons ,Immediate Relative etc covered under the Code. The date of the Board Meeting for consideration of the Un Audited Financial Results of the Company for the Quarter ended 30" September 2026 will be intimated in due course. Accordingly, all Designated Persons and their immediate relatives are advised not to trade in the securities of the Company during the aforesaid trading window closure period. Thanking you, Yours Faithfully, FOR SANDU PHARMACEUTICALS LIMITED. SPCETE Pratika Mhambray Company Secretary & Compliance Officer A36512 AN 1SO 9001:2015 CERTIFIED ORGANISATION Corporate Office: P. B. No. 17201, Sandu Nagar, D. K. Sandu Marg, Chembur, Mumbai - 400 071. Tel.: +91 22 2528 4402 / 3306, E-mail: info@sandu.in